UB Paderborn / Katalog / Suche / in CDI

Hematopoietic neoplasms with 9p24/JAK2 rearrangement: a multicenter study

Modern pathology, 2019-04, Vol.32 (4), p.490-498

2019

Link zum Volltext

Verfügbarkeit prüfen

Indolent small intestinal CD4+ T-cell lymphoma is a distinct entity with unique biologic and clinical features

PloS one, 2013-07, Vol.8 (7), p.e68343-e68343

2013

Link zum Volltext

Verfügbarkeit prüfen

The role of BRCA1‐associated protein 1 in the diagnosis of malignant mesothelioma in effusion and fine‐needle aspiration cytology

Diagnostic cytopathology, 2019-03, Vol.47 (3), p.160-165

2019

Link zum Volltext

Verfügbarkeit prüfen

So-called "blast phase" of chronic myelomonocytic leukemia: a plea for uniform terminology

Leukemia, 2018-12, Vol.32 (12), p.2716-2716

Margolskee, Elizabeth

2018

Link zum Volltext

Verfügbarkeit prüfen

Comparison of therapy‐related and de novo core binding factor acute myeloid leukemia: A bone marrow pathology group study

American journal of hematology, 2020-07, Vol.95 (7), p.799-808

2020

Link zum Volltext

Verfügbarkeit prüfen

Cytological diagnosis of papillary thyroid carcinoma with tall cells on ThinPrep liquid‐based cytology

Diagnostic cytopathology, 2019-06, Vol.47 (6), p.541-546

2019

Link zum Volltext

Verfügbarkeit prüfen

Cytomorphologic features distinguishing Bethesda category IV thyroid lesions from parathyroid

CytoJournal, 2017, Vol.14 (1), p.10

2017

Link zum Volltext

Verfügbarkeit prüfen

Hypermetabolic Residual Retroperitoneal Mass After Chemotherapy for Primary Seminoma

Urology (Ridgewood, N.J.), 2015-05, Vol.85 (5), p.987-990

2015

Link zum Volltext

Verfügbarkeit prüfen

Leukoerythroblastosis and plasmacytoid lymphocytes in a child with SARS-CoV-2–associated multisystem inflammatory syndrome

Blood, 2020-08, Vol.136 (7), p.914-914

2020

Link zum Volltext

Verfügbarkeit prüfen

Loss of surface CD3 expression in allogeneic CAR T‐cells

American journal of hematology, 2020-09, Vol.95 (9), p.1115-1116

2020

Link zum Volltext

Verfügbarkeit prüfen

Pathogenesis of Peripheral T Cell Lymphoma

Annual review of pathology, 2018-01, Vol.13, p.293

2018

Link zum Volltext

Verfügbarkeit prüfen

Acute Myeloid Leukemia Presenting as Myeloid Sarcoma with a Predisposition to the Gynecologic Tract

Case reports in oncological medicine, 2019, Vol.2019, p.4189275-5

2019

Link zum Volltext

Verfügbarkeit prüfen

Transdifferentiation of B‐lymphoblastic leukemia to histiocytic sarcoma after immunotherapy

American journal of hematology, 2023-08, Vol.98 (8), p.E216-E218

2023

Link zum Volltext

Verfügbarkeit prüfen

Rosai–Dorfman Disease Harboring an Activating KRAS K117N Missense Mutation

Head & neck pathology (Totowa, N.J.), 2016-09, Vol.10 (3), p.394-399

2016

Link zum Volltext

Verfügbarkeit prüfen

Targeted next generation sequencing of breast implant‐associated anaplastic large cell lymphoma reveals mutations in JAK/STAT signalling pathway genes, TP53 and DNMT3A

British journal of haematology, 2018-03, Vol.180 (5), p.741-744

2018

Link zum Volltext

Verfügbarkeit prüfen

Quantification of Neutrophil Extracellular Traps (NETs) in Pediatric Patients with COVID-19 and Multisystem Inflammatory Syndrome (MIS-C) through Plasma and Peripheral Smear Analysis

Blood, 2022-11, Vol.140 (Supplement 1), p.5481-5482

2022

Link zum Volltext

Verfügbarkeit prüfen

Haematology laboratory parameters to assess efficacy of CD19‐, CD22‐, CD33‐, and CD123‐directed chimeric antigen receptor T‐cell therapy in haematological malignancies

International journal of laboratory hematology, 2022-08, Vol.44 (4), p.750-758

2022

Link zum Volltext

Verfügbarkeit prüfen

Combined use of tofacitinib (pan-JAK inhibitor) and ruxolitinib (a JAK1/2 inhibitor) for refractory T-cell prolymphocytic leukemia (T-PLL) with a JAK3 mutation

Leukemia & lymphoma, 2019-06, Vol.60 (7), p.1626-1631

2019

Link zum Volltext

Verfügbarkeit prüfen

Haematology laboratory parameters to assess efficacy of CD19 ‐, CD22 ‐, CD33 ‐, and CD123 ‐directed c himeric antigen receptor T‐cell therapy in haematological malignancies

International journal of laboratory hematology, 2022-08, Vol.44 (4), p.750-758

2022

Link zum Volltext

Verfügbarkeit prüfen

Evaluation of Bone Marrowmmorphology in Addition to JAK2 Allele Burden Is Essential for Assessing Disease Status in Recombinant Interferon Alpha-Treated Polycythemia Vera Patients

Blood, 2016-12, Vol.128 (22), p.5471-5471

2016

Link zum Volltext

Verfügbarkeit prüfen

Myeloid neoplasms with isolated del(5q) and JAK2 V617F mutation: a "grey zone" combination of myelodysplastic and myeloproliferative features?

Haematologica (Roma), 2020-06, Vol.105 (6), p.e276-e279

2020

Link zum Volltext

Verfügbarkeit prüfen

JAK2 V617F‐positive acute myeloid leukaemia (AML): a comparison between de novo AML and secondary AML transformed from an underlying myeloproliferative neoplasm. A study from the Bone Marrow Pathology Group

British journal of haematology, 2018-07, Vol.182 (1), p.78-85

2018

Link zum Volltext

Verfügbarkeit prüfen

Genetic landscape of T- and NK-cell post-transplant lymphoproliferative disorders

Oncotarget, 2016-06, Vol.7 (25), p.37636-37648

2016

Link zum Volltext

Verfügbarkeit prüfen

Evaluation of bone marrow morphology is essential for assessing disease status in recombinant interferon α-treated polycythemia vera patients

Haematologica (Roma), 2017-03, Vol.102 (3), p.e97-e99

2017

Link zum Volltext

Verfügbarkeit prüfen

An erythematous indurated plaque on the neck of a 12‐year‐old girl

Pediatric dermatology, 2022-05, Vol.39 (3), p.449-451

2022

Link zum Volltext

Verfügbarkeit prüfen

Menü

Weitere Dienste

Einstellungen

Hematopoietic neoplasms with 9p24/JAK2 rearrangement: a multicenter study

Indolent small intestinal CD4+ T-cell lymphoma is a distinct entity with unique biologic and clinical features

The role of BRCA1‐associated protein 1 in the diagnosis of malignant mesothelioma in effusion and fine‐needle aspiration cytology

So-called "blast phase" of chronic myelomonocytic leukemia: a plea for uniform terminology

Comparison of therapy‐related and de novo core binding factor acute myeloid leukemia: A bone marrow pathology group study

Cytological diagnosis of papillary thyroid carcinoma with tall cells on ThinPrep liquid‐based cytology

Cytomorphologic features distinguishing Bethesda category IV thyroid lesions from parathyroid

Hypermetabolic Residual Retroperitoneal Mass After Chemotherapy for Primary Seminoma

Leukoerythroblastosis and plasmacytoid lymphocytes in a child with SARS-CoV-2–associated multisystem inflammatory syndrome

Loss of surface CD3 expression in allogeneic CAR T‐cells

Pathogenesis of Peripheral T Cell Lymphoma

Acute Myeloid Leukemia Presenting as Myeloid Sarcoma with a Predisposition to the Gynecologic Tract

Transdifferentiation of B‐lymphoblastic leukemia to histiocytic sarcoma after immunotherapy

Rosai–Dorfman Disease Harboring an Activating KRAS K117N Missense Mutation

Targeted next generation sequencing of breast implant‐associated anaplastic large cell lymphoma reveals mutations in JAK/STAT signalling pathway genes, TP53 and DNMT3A

Quantification of Neutrophil Extracellular Traps (NETs) in Pediatric Patients with COVID-19 and Multisystem Inflammatory Syndrome (MIS-C) through Plasma and Peripheral Smear Analysis

Haematology laboratory parameters to assess efficacy of CD19‐, CD22‐, CD33‐, and CD123‐directed chimeric antigen receptor T‐cell therapy in haematological malignancies

Combined use of tofacitinib (pan-JAK inhibitor) and ruxolitinib (a JAK1/2 inhibitor) for refractory T-cell prolymphocytic leukemia (T-PLL) with a JAK3 mutation

Haematology laboratory parameters to assess efficacy of CD19 ‐, CD22 ‐, CD33 ‐, and CD123 ‐directed c himeric antigen receptor T‐cell therapy in haematological malignancies

Evaluation of Bone Marrowmmorphology in Addition to JAK2 Allele Burden Is Essential for Assessing Disease Status in Recombinant Interferon Alpha-Treated Polycythemia Vera Patients

Myeloid neoplasms with isolated del(5q) and JAK2 V617F mutation: a "grey zone" combination of myelodysplastic and myeloproliferative features?

JAK2 V617F‐positive acute myeloid leukaemia (AML): a comparison between de novo AML and secondary AML transformed from an underlying myeloproliferative neoplasm. A study from the Bone Marrow Pathology Group

Genetic landscape of T- and NK-cell post-transplant lymphoproliferative disorders

Evaluation of bone marrow morphology is essential for assessing disease status in recombinant interferon α-treated polycythemia vera patients

An erythematous indurated plaque on the neck of a 12‐year‐old girl

Suchergebnisse filtern